{"document_type": "article", "byline": {"person": [{"role": "reported", "firstname": "Peter", "organization": "", "rank": 1, "lastname": "EAVIS"}], "original": "By PETER EAVIS"}, "news_desk": "Business", "slideshow_credits": null, "abstract": "Admission by Valeant Pharmaceuticals that it improperly booked $58 million in revenue, while minor in comparison to company's overall financial scope, could lend credence to longstanding accusations of flawed accounting practices; company has acknowledged that other lapses may require review. ", "multimedia": [{"type": "image", "url": "images/2016/03/29/business/29db-valeantaccounting/29db-valeantaccounting-thumbWide.jpg", "legacy": {"wide": "images/2016/03/29/business/29db-valeantaccounting/29db-valeantaccounting-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "width": 190, "subtype": "wide", "height": 126}, {"type": "image", "url": "images/2016/03/29/business/29db-valeantaccounting/29db-valeantaccounting-articleLarge.jpg", "legacy": {"xlarge": "images/2016/03/29/business/29db-valeantaccounting/29db-valeantaccounting-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "width": 600, "subtype": "xlarge", "height": 400}, {"type": "image", "url": "images/2016/03/29/business/29db-valeantaccounting/29db-valeantaccounting-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/03/29/business/29db-valeantaccounting/29db-valeantaccounting-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "width": 75, "subtype": "thumbnail", "height": 75}], "headline": {"print_headline": "Valeant\u2019s Small Accounting Error Is a Warning Sign to Investors of Bigger Problems", "main": "Valeant\u2019s Accounting Error a Warning Sign of Bigger Problems"}, "print_page": "3", "keywords": [{"value": "Valeant Pharmaceuticals International Inc", "is_major": "Y", "rank": "1", "name": "organizations"}, {"value": "Accounting and Accountants", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Philidor Rx Services LLC", "is_major": "N", "rank": "4", "name": "organizations"}, {"value": "Bausch & Lomb Incorporated", "is_major": "N", "rank": "5", "name": "organizations"}, {"value": "Pearson, John Michael (1959- )", "is_major": "N", "rank": "6", "name": "persons"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "7", "name": "subject"}], "snippet": "Investors have other reasons to remain concerned about the accuracy of the company\u2019s financial statements.", "source": "The New York Times", "lead_paragraph": "Investors have other reasons to remain concerned about the accuracy of the company\u2019s financial statements.", "word_count": "1208", "pub_date": "2016-03-29T00:00:00Z", "subsection_name": "DealBook", "blog": [], "type_of_material": "News", "section_name": "Business Day", "web_url": "http://www.nytimes.com/2016/03/29/business/dealbook/valeants-accounting-error-a-warning-sign-of-bigger-problems.html", "_id": "56f99b2238f0d874a87cb052"}